These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium. Shaw DD; Bach-Gansmo T; Dahlstrom K Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616 [TBL] [Abstract][Full Text] [Related]
26. Cognitive and affective changes after myelography: a comparison of metrizamide and iohexol. Ratcliff G; Sandler S; Latchaw R AJR Am J Roentgenol; 1986 Oct; 147(4):777-81. PubMed ID: 3489380 [TBL] [Abstract][Full Text] [Related]
27. [A randomized, double-blind clinical trial of 2 nonionic contrast media for myelography]. Lovrencić M; Klanfar Z; Jakovac I Lijec Vjesn; 1986 Apr; 108(4):141-6. PubMed ID: 3520199 [No Abstract] [Full Text] [Related]
28. Clinical trial of iohexol in lumbar myelography. Kendall B; Harrison M; Schneidau A Acta Radiol Diagn (Stockh); 1983; 24(6):507-10. PubMed ID: 6322525 [TBL] [Abstract][Full Text] [Related]
29. Iohexol in lumbar myelography: preliminary results from an open, noncomparative multicenter clinical study. Eldevik OP; Nakstad P; Kendall BE; Hindmarsh T AJNR Am J Neuroradiol; 1983; 4(3):299-301. PubMed ID: 6410725 [TBL] [Abstract][Full Text] [Related]
30. Comparison of metrizamide and iohexol for cisternal myelographic examination of dogs. Puglisi TA; Green RW; Hall CL; Read WK; Green RA; Tangner CH; Mann FA; Hobson HP Am J Vet Res; 1986 Aug; 47(8):1863-9. PubMed ID: 3530068 [TBL] [Abstract][Full Text] [Related]
31. Experimental study of arachnoiditis from iohexol, an investigational nonionic aqueous contrast medium. Haughton VM; Ho KC; Lipman BT AJNR Am J Neuroradiol; 1982; 3(4):375-7. PubMed ID: 6810669 [TBL] [Abstract][Full Text] [Related]
32. Iohexol 240 mgr I/ml and metrizamide 240 mgr I/ml in lumbar myelography. Report from a randomized double blind study. Valk J; Hazenberg GJ; van Duijn H; Crezee F; Olislagers-De Slegte R Diagn Imaging Clin Med; 1986; 55(3):114-20. PubMed ID: 3522040 [TBL] [Abstract][Full Text] [Related]
33. Iohexol in patients with previous adverse reactions to contrast media. Holtås S Invest Radiol; 1984; 19(6):563-5. PubMed ID: 6511264 [TBL] [Abstract][Full Text] [Related]
34. Intrathecal toxicity of iohexol vs. metrizamide. Survey and current state. Haughton VM Invest Radiol; 1985; 20(1 Suppl):S14-7. PubMed ID: 3918951 [TBL] [Abstract][Full Text] [Related]
35. Iohexol vs. iopamidol for myelography. Lamb JT Invest Radiol; 1985; 20(1 Suppl):S37-43. PubMed ID: 3882615 [TBL] [Abstract][Full Text] [Related]
36. [Comparison of the side-effects of iohexol and metrizamide in lumbar myelography/radiculography]. Lesak F Ugeskr Laeger; 1986 May; 148(20):1206-8. PubMed ID: 3727099 [No Abstract] [Full Text] [Related]
37. Myelography with a dimeric (iodixanol) and a monomeric (iohexol) contrast medium: a clinical multicentre comparative study. Skalpe IO; Bonneville JF; Grane P; Gyldenstedt C; Otto B; Kristoffersen DT; Svaland MG Eur Radiol; 1998; 8(6):1054-7. PubMed ID: 9683718 [TBL] [Abstract][Full Text] [Related]
39. Iotrolan, a nonionic dimeric contrast medium in myelography. Bien S; Schumacher M; Berger W; Wenzel-Hora BI Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():158-60. PubMed ID: 2568785 [TBL] [Abstract][Full Text] [Related]